Marken

The pharmaceutical industry is racing to redefine weight loss treatments, with a few leading companies dominating the landscape while others pursue advancements in efficacy, convenience, and fewer side effects. Upcoming trial results in the next six months could potentially reshape the market and drive a new phase of innovation in GLP-1 agonists. 💡 Read the article: https://lnkd.in/geTndYSc #GLP1 #Patients #Healthcare #Innovation #Pharmaceutical #Pharma #WeightLoss #ObesityTrials

Marken is proud to announce we have received a positive PSCI - Pharmaceutical Supply Chain Initiative (PSCI) audit. The PSCI is an association of healthcare and pharmaceutical companies dedicated to improving safety, environmental, and socially responsible outcomes in the industry.   This report reflects our unwavering focus on excellence in ethics, labor and human rights, sustainability, and health and safety. As the clinical and advanced therapy subsidiary of UPS Healthcare, we lead by example and remain dedicated to implementing operational efficiencies and processes through innovative solutions like reusable and recyclable packaging, optimizing renewable energy sourcing, greenhouse gas emission reductions, and closed loop logistics.   Our audit is now available for review by PSCI members on the PSCI platform. Discover how we stay committed to reducing our environmental impact: https://lnkd.in/gWY8MbsN   #Marken #Logistics #SupplyChain #ESG #DEI #Sustainability #Healthcare #Patients

How do we support clinical trials in regions impacted by natural disasters, geopolitical instability, or global crises? Join Marken’s Senior Regional Operations Director, EMEA, Adrian Karrer, and industry leaders for a webinar hosted by Novotech to discover how we ensure patients receive the medicine and supplies they need, even in the most challenging logistical conditions. Listen in as they discuss key topics such as: ✔ Essential strategies for sponsors entering emerging markets. ✔ Insights on crisis response from natural disasters to geopolitical tensions. ✔ Maintaining data integrity and operational resilience while navigating disruptions.   Whether you are managing the complexities of supply chains, participant safety, or regulatory compliance, you will gain actionable insights and forward-thinking strategies to future-proof your clinical trials.   Mark your calendar for November 27 at 3:00 PM (CET) and secure your spot - Register now for the webinar: https://lnkd.in/e6vgTVz4   #Marken #ClinicalTrials #SupplyChain #Logistics #PatientSafety #RegulatoryCompliance #Patients #Healthcare #Pharma

Clinical trials face unique challenges during the holiday season from patient engagement hurdles to logistical roadblocks and understaffed sites. But with patient-centric solutions, like Home Healthcare (HHC), and streamlined logistics, you can turn seasonal chaos into seamless trial continuity. At Marken, we're committed to ensuring your trials continue without disruption during the busiest time of the year, while prioritizing the well-being and convenience of your patients and investigator sites. Here’s how our global network and innovative solutions support the clinical to commercial journey:   - HHC: Bring trials to your patients’ homes, eliminating travel hassles and keeping participation steady during the holidays. - Central Pharmacy: Globally positioned to simplify logistical and product complexities to keep trials on track and stress-free. - Site Support Services: Allow your sites to focus on what matters most - patient care - while we handle the logistics and provide supplemental staffing as needed.   Connect with our HHC experts today to discover how we align with your protocols and deliver patient-focused services during the holiday season and beyond: expert@marken.com   #Marken #PatientCentric #ClinicalTrials #Pharma #Sites #Sponsors #Patients #HomeHealthcare #Commercial #Logistics #SupplyChain

With increasing pressure on the pharmaceutical industry to align with environmental, social, and governance (ESG) initiatives, the demand for sustainable, socially responsible, and cost-efficient practices has never been greater. Join our Marken webinar on December 5, at 9:00am (EST), to learn about new methodologies to reduce waste, improve equity, and drive process efficiency.   Hear from Deahne Baker, Director of Sustainability, Marken, Sandra Voss, Senior Manager of Sustainability, Marken, André Annema, Co-Owner; Sustainability & Strategy; Partnerships, Acquisitions & Divestments, AllChiefs, and Esmeralda Frecken, Lead Consultant, Business Consulting and Transformation, AllChiefs, as they share success stories, lessons learned, and actionable strategies for building ESG programs that drive societal change and reduce environmental impact throughout the supply chain.   Don’t miss your chance to gain valuable insights on: - Sustainable logistics investments, such as energy-efficient cold-chain technologies and eco-friendly packaging solutions - Advanced technologies, renewable energy, and digital tools that are driving ESG - How transparent ESG metrics and reporting are becoming industry standards - Collaboration strategies across the pharma supply chain to achieve ESG goals   Secure your spot today for our complimentary webinar: https://lnkd.in/e-i2hASK   Unable to attend? Register now and watch the recorded webinar later, at a time convenient for you: https://lnkd.in/e-i2hASK   #Marken #Sustainability #ESG #RenewableEnergy #CarbonReduction #SupplyChain #PrecisionLogistics #Healthcare

Ukraine’s clinical trial sector continues to adapt and strengthen, finding ways to support critical research needs even amidst ongoing challenges. The region’s pharmaceutical industry is increasingly focused on building supply chain contingency plans with agile infrastructures to ensure continuity and maintain secure handling of trial materials.   Marken’s Kyiv, Ukraine depot is a resilient hub for time- and temperature-sensitive shipments with onsite experts trained to comply with GMP and GDP standards. Our Importer of Record (IOR) services simplify the logistics pipeline, providing reliable storage and distribution across all temperature ranges and allowing us to rapidly adjust distribution models - whether direct-to-site or direct-to-patient - to meet your needs.   Discover how our trade compliance experts coordinate global and local regulatory requirements with our onsite depot team to keep essential medicines and supplies moving effectively in the region and beyond: http://ow.ly/2tR250MEFhj   #Marken #UkraineGMPDepot #TradeCompliance #RegulatoryExpertise #ClinicalSupplyChain

The field of Advanced Therapy Medicinal Products (ATMPs) has made remarkable strides, offering innovative treatments from cell and gene therapies to nucleic acid therapies and the raw materials used to manufacture them. However, ensuring these therapies reach patients safely and efficiently poses unique logistical challenges due to their complex nature and stringent regulatory requirements. From specialized handling to real-time monitoring, the ATMP supply chain must adapt to maintain product integrity across global routes.   In our latest blog post, ‘Mastering the Advanced Therapy Supply Chain,’ we dive into the intricate world of advanced therapy logistics, where every shipment could mean a life saved. Learn how cutting-edge innovations, like the Internet of Things enabled monitoring, AI-driven decision-making, and ultra-cold storage solutions, are reshaping the supply chain for therapies that can’t afford a single mistake. Discover the essential role of cross-industry collaboration, where coordination with sponsors, manufacturers, clinicians, regulatory entities, and precision logistics partners, ensures these groundbreaking treatments reach patients on time and within specifications.   Explore the challenges, breakthroughs, and future of ATMP logistics and explore what it takes to deliver tomorrow’s most advanced medicines: https://lnkd.in/eM6wrDAk   #Marken #AdvanceTherapy #CellandGeneTherapy #CARTCellTherapy #AdvancedTherapySupplyChain #NucleicAcidTherapies

“Think creatively - We know we have a group of diabetic patients who may be eligible for the GLP-1 candidate program and need to do a massive screening. Consider the possibility of temporarily augmenting our site staff with additional personnel for that week so we can identify those [patients] that will be eligible for enrollment.” - Robin (Averbuck) Marcus, Head of Global Decentralized Trials Market Development, Marken   It’s not too late to join Marken’s patient-centric services expert, Robin Marcus, and Jimmy Bechtel, MBA, VP, Site Engagement, Society for Clinical Research Sites (SCRS), for an in-depth discussion on how flexible site augmentation models and decentralized strategies are driving efficiency, accelerating patient enrollment, and helping clinical sites manage unprecedented demands and critical staffing challenges. Discover practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, empowering your team to focus on what matters most – patient care.   Access the complimentary recording of our latest webinar, ‘Streamlining Clinical Trials with Site Augmentation,’ and listen at a time convenient for you: https://lnkd.in/etYkY8-i   #Site #SiteAugmentation #PatientCentric #HHC #DCT #DecentralizedTrials #HybridTrials #Marken #Healthcare #ClinicalSites #PatientCare

How does your precision logistics partner stay ahead in today’s ever-evolving landscape?   In October, we were front and center at key events, engaging with industry trailblazers on the latest biopharma, healthcare, and supply chain innovations. Here’s a look at our month: - Hyderabad, India: Marken and UPS Healthcare hosted an exclusive event focused on India’s biopharmaceutical landscape, discussing temp-controlled logistics and the vital role of airlines in healthcare supply chains. - Cell & Gene Meeting on the Mesa, AZ: Our experts discussed Marken's single-source solutions for advanced therapies. - Pink Festival, Korea: Marken’s Korea team joined over 1,000 participants in the Korean Breast Health Foundation's ‘Pink Festival’ to promote breast cancer awareness and early detection. - EAP Summit, London: Marken’s Nicola Laschi and Warsame Ali joined a panel exploring the importance of cold chain integrity in early access programs. - GCSG Knowledge Forum, Malta: Marken’s Manishaa O'Brien and Zarina Abdoel-Piroe led a session on optimizing depot selection to improve patient access. - UPS Healthcare Forum, Budapest: Marken’s Chief Operating Officer, Doaa Fathallah, and SVP, Innovation and Strategic Operations, Dan Bell, discussed the pivotal role precision logistics plays in advanced therapies and how digital innovations are transforming the industry. - World Orphan Drug Congress, Barcelona: Marken’s Head of Global Decentralized Trials Market Development, Robin (Averbuck) Marcus, discussed how patient-centric solutions can remove barriers, improving patient access in rare disease studies. - NECSO Annual Meeting, MA: Marken expert, Andrew Lawrence, MBA, highlighted our latest packaging advancements and technology innovations.   - Site Augmentation Webinar: Robin Marcus, Head of Global Decentralized Trials Market Development, Marken, and a featured guest explored how site augmentation programs streamline clinical trials. - Leukemia and Lymphoma Society's Light the Night, NC: Marken’s Raleigh-Durham team joined the community to honor, support, and remember those affected by blood cancers.   - Turkish Cargo Visit, Turkey: Chiara Venuti, VP, Global Drug Distribution, Marken, toured Turkish Cargo’s temp-controlled pharma facilities in Istanbul, discussing current pharma offerings and future collaborations. - Executive Strategy Meeting, PA: Our Chief Operating Officer, Doaa Fathallah, and VP, EMEA Logistics, Frédéric Maurice, visited our GMP depot in Malvern, PA, connecting with local leadership to discuss operational advancements and strategic growth plans across North America.   The month concluded with Chiara Venuti, VP, Global Drug Distribution, at Aviation Connect – Airfreight Pharma where she led a joint presentation on reducing environmental impact while maintaining the speed and precision required by the biopharma industry. Learn where we will be next: https://lnkd.in/gc4RUZSp #Marken #Healthcare #PrecisionLogistics

The busiest time of the year is here, and the air cargo market is feeling the pressure as capacity is tight and spot rates are rising. In our recent blog post, Marken’s VP, Global Drug Distribution, Chiara Venuti, shares actionable insights to keep your pharma supply chain strong through the holiday rush.   Key topics covered in our blog post include:   - Expected shipping volumes and cost trends for Q4 - Most impacted shipping modes and routes during peak season - Key destinations prone to congestion - Why early planning is essential to avoid costly delays   Don’t let this holiday season catch you unprepared - With solutions that prioritize on-time delivery, cost efficiency, and end-to-end visibility, Marken is here to help you meet your critical year-end goals seamlessly. Read the full blog post: https://lnkd.in/eD3EPFzR   #Marken #BulkDrug #PharmaceuticalDrug #DrugDistribution #SupplyChain #Logistics #Visibility #DrugShipment